Skip to main content
Clinical Trials/SLCTR/2014/005
SLCTR/2014/005
Not yet recruiting
Phase 2

A randomized placebo controlled trial on the effect of insulin in reducing skeletal muscle reperfusion injury.

Professorial Surgical Unit0 sites24 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Reperfusion injury
Sponsor
Professorial Surgical Unit
Enrollment
24
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Professorial Surgical Unit

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients undergoing a vascular surgical intervention requiring clamping of aortic / iliac or femoral blood vessels for more than 30 minutes duration and/or
  • 2\. Patients with acute limb ischaemia, (Class ll Acute Limb Ischaemia, Society for Vascular Surgery) needing revascularization.

Exclusion Criteria

  • 1\. Patients with any of the following.
  • a)Insulin\-treated diabetes mellitus
  • b)glucocorticoid treatment
  • c)systemic infection
  • d)congestive heart failure.
  • 2\. Patients for whom amputation rather than revascularization is indicated.
  • 3\. Patients below the age of 18 years

Outcomes

Primary Outcomes

Not specified

Similar Trials